Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Biomaterials. 2011 Dec 3;33(6):1863–1872. doi: 10.1016/j.biomaterials.2011.11.029

Figure 8.

Figure 8

Summary of CD133 changes and cell viability. Black columns: CD133 expression level (%); gray columns: cell viability (%). The data are presented as mean±SD of the experiments done in triplicate. *, p<0.05; **, p<0.01. Free cyclopamine and docetaxel treatments were compared to DMSO treatment; HPMA copolymer-cyclopamine conjugate was compared to untreated group.